PURPOSE: To investigate the prognostic value of biomarkers in male breast carcinoma
(MBC). PATIENTS AND METHODS: Fifty patients (mean age, 62.2 years) with invasive …

Male breast cancer is rare, and experience of it in any single institution is limited. Our current
understanding regarding its biology, natural history, and treatment strategies has been …

BACKGROUND In contrast to female breast carcinoma, information regarding the
prevalence and prognostic information of new molecular markers is limited in male breast …

Introduction Male breast cancer (MBC) is a rare, yet potentially aggressive disease.
Although literature regarding female breast cancer (FBC) is extensive, little is known about …

The prognostic role of ploidy status, S phase fraction, estrogen and progesterone receptor
status, and the expression of p 53 and erbB-2 protein in male breast carcinoma (MBC) …

Background and Objectives p53, c‐erbB‐2, and tumor microvascular density have been
shown to be potential prognostic tools in female breast cancer. Our objective was to assess …

Background male breast cancer is uncommon and studies regarding the potential clinical
relevance of the histopathological and immunohistochemical features are infrequently …

BACKGROUND Although breast cancer in men is far less common than breast cancer in
women, it is associated with a less favorable prognosis. Conventional histopathologic …

Background Male breast cancer has traditionally been compared with female breast cancer,
using the same staging system and prognostic indicators. A variety of histochemical and …

Kornegoor R, Verschuur‐Maes AHJ, Buerger H, Hogenes MC, de Bruin PC, Oudejans JJ,
Hinrichs B & van Diest PJ (2012) Histopathology Immunophenotyping of male breast cancer …